Nicoline van Hattem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nicoline van Hattem has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Douwe Ekke Atsma
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
3 shared publications Niels H Chavannes
Department of Public Health and Primary Care, Leiden University Medical Centre , 2333 ZA, Leiden
2 shared publicationsTobias N Bonten
Department of Public Health and Primary Care, Leiden University Medical Centre , 2333 ZA, Leiden
2 shared publications- Anna Veronica Silven
Leiden University Medical Center, The Netherlands, National eHealth Living Lab, Leiden 2333 ZA, the Netherlands; Leiden University Medical Center, The Netherlands, Department of Public Health and Primary Care, 2333 ZA the Netherlands
1 shared publication Bart A Mertens
Department of Biomedical Data Sciences, Leiden University Medical Center , 2333 ZA, Leiden
1 shared publication- Bart J. A. Mertens
Medical Statistics, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 28 September 2026
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 14, e79512
A Cardiovascular Care Pathway Supported by Remote Patient Management in Dutch Primary Care: Cost-Effectiveness, Budget Impact, and Workload Analysis
Background: Remote patient management (RPM) that supports patient self-monitoring of vital parameters and lifestyle factors may improve cardiovascular risk management (CVRM) in primary care. However, large-scale implementation remains limited, partly due to insufficient evidence on long-term value for money, budget impact, and implications for health care professionals' workload. Objective: This study aimed to estimate the long-term cost-effectiveness, 5-year health care budget impact, and expected changes in general practitioner (GP) and practice nurse (PN) workload associated with the CVRM-Box intervention in the Netherlands. Methods: We conducted a model-based economic evaluation comparing CVRM-Box with care as usual in Dutch primary care integrated CVRM programs. CVRM-Box is a multicomponent RPM intervention comprising a digital blood pressure (BP) monitor, digital weight scale, step counter/activity tracker, and a mobile app, with measurements transferred to the GP practice for periodic review. A time-inhomogeneous cohort Markov model simulated lifetime transitions among health states, including at-risk, post–myocardial infarction (MI), poststroke, recurrent events, cardiovascular death, and noncardiovascular death. Cardiovascular risks were modeled using prediction equations (SCORE2, SCORE2-OP, and SMART2) populated with subgroup-specific risk factor profiles. Intervention effects were modeled as changes in systolic BP derived from a matched cohort study of CVRM-Box. Other key parameters (costs and utilities) were similarly obtained from the matched cohort study, or routine primary care data, and published sources. Outcomes included incremental cost-effectiveness ratios (ICERs, indicating cost per quality-adjusted life year [QALY] gained), cost-effectiveness probabilities, 5-year health care budget impact, and an exploratory workload analysis estimating annual changes in visit time and remote consultation frequency for GPs and PNs. Probabilistic and scenario uncertainty analyses were performed. Results: In the overall population, CVRM-Box increased costs and QALYs versus care as usual, yielding an ICER of €17,340/QALY gained (EUR €1=US $1.11 as of 29 December 2023) and a 60% probability of cost-effectiveness at a willingness-to-pay threshold of €20,000/QALY. Cost-effectiveness was more favorable in higher-risk subgroups (uncontrolled BP and/or prior MI/stroke), with ≥70% probability of cost-effectiveness at €20,000/QALY, whereas in the lower-risk subgroup with controlled BP and no prior MI/stroke, the intervention is unlikely to be cost-effective (ICER: €42,384/QALY). The 5-year health care budget impact was €2.9 million and €662.2 million for regional and national rollout, respectively. In a typical Dutch primary care practice, the CVRM-Box reduced PN workload by 25.9 h and 44.7 remote consultations annually, while the change in GP workload was negligible (0.5 h; 3.3 remote consultations). Conclusions: The CVRM-Box multicomponent RPM intervention is likely to be cost-effective among high-risk subgroups but not in lower-risk groups. The intervention further reduces PN workload but not GP workload. Results primarily apply to the Dutch context and may not generalize to health care systems with different payment/incentive arrangements. Additionally, long-term outcomes were modeled using prediction models rather than observed cardiovascular events. Nonetheless, our findings provide an argument for implementation in primary care for higher-risk subgroups.
- 28 September 2026
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 14, e79512
Open AccessA Cardiovascular Care Pathway Supported by Remote Patient Management in Dutch Primary Care: Cost-Effectiveness, Budget Impact, and Workload Analysis
Background: Remote patient management (RPM) that supports patient self-monitoring of vital parameters and lifestyle factors may improve cardiovascular risk management (CVRM) in primary care. However, large-scale implementation remains limited, partly due to insufficient evidence on long-term value for money, budget impact, and implications for health care professionals' workload. Objective: This study aimed to estimate the long-term cost-effectiveness, 5-year health care budget impact, and expected changes in general practitioner (GP) and practice nurse (PN) workload associated with the CVRM-Box intervention in the Netherlands. Methods: We conducted a model-based economic evaluation comparing CVRM-Box with care as usual in Dutch primary care integrated CVRM programs. CVRM-Box is a multicomponent RPM intervention comprising a digital blood pressure (BP) monitor, digital weight scale, step counter/activity tracker, and a mobile app, with measurements transferred to the GP practice for periodic review. A time-inhomogeneous cohort Markov model simulated lifetime transitions among health states, including at-risk, post–myocardial infarction (MI), poststroke, recurrent events, cardiovascular death, and noncardiovascular death. Cardiovascular risks were modeled using prediction equations (SCORE2, SCORE2-OP, and SMART2) populated with subgroup-specific risk factor profiles. Intervention effects were modeled as changes in systolic BP derived from a matched cohort study of CVRM-Box. Other key parameters (costs and utilities) were similarly obtained from the matched cohort study, or routine primary care data, and published sources. Outcomes included incremental cost-effectiveness ratios (ICERs, indicating cost per quality-adjusted life year [QALY] gained), cost-effectiveness probabilities, 5-year health care budget impact, and an exploratory workload analysis estimating annual changes in visit time and remote consultation frequency for GPs and PNs. Probabilistic and scenario uncertainty analyses were performed. Results: In the overall population, CVRM-Box increased costs and QALYs versus care as usual, yielding an ICER of €17,340/QALY gained (EUR €1=US $1.11 as of 29 December 2023) and a 60% probability of cost-effectiveness at a willingness-to-pay threshold of €20,000/QALY. Cost-effectiveness was more favorable in higher-risk subgroups (uncontrolled BP and/or prior MI/stroke), with ≥70% probability of cost-effectiveness at €20,000/QALY, whereas in the lower-risk subgroup with controlled BP and no prior MI/stroke, the intervention is unlikely to be cost-effective (ICER: €42,384/QALY). The 5-year health care budget impact was €2.9 million and €662.2 million for regional and national rollout, respectively. In a typical Dutch primary care practice, the CVRM-Box reduced PN workload by 25.9 h and 44.7 remote consultations annually, while the change in GP workload was negligible (0.5 h; 3.3 remote consultations). Conclusions: The CVRM-Box multicomponent RPM intervention is likely to be cost-effective among high-risk subgroups but not in lower-risk groups. The intervention further reduces PN workload but not GP workload. Results primarily apply to the Dutch context and may not generalize to health care systems with different payment/incentive arrangements. Additionally, long-term outcomes were modeled using prediction models rather than observed cardiovascular events. Nonetheless, our findings provide an argument for implementation in primary care for higher-risk subgroups.
- Open Access
- 21 September 2024
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 42 (2)
The effect and implementation of the COVID Box, a remote patient monitoring system for patients with a COVID-19 infection in primary care: a matched cohort study
At the onset of the COVID-19 pandemic, the pressure on hospitals increased tremendously. To alleviate this pressure, a remote patient monitoring system called the COVID Box was developed and implemented in primary care. The aim was to assess whether the COVID Box in primary care could reduce emergency department (ED) referrals due to a COVID-19 infection. A matched cohort study was performed between December 2020 and June 2021. Patients with a COVID-19 infection in need of intensive monitoring based on the clinical judgement of their own general practitioner received the COVID Box in primary care combining home monitoring of vital parameters with daily video consultations. The control group was retrospectively matched by propensity score matching. We conducted a subgroup analysis in higher-risk patients with oxygen saturation measurements, considering oxygen saturation as a critical parameter for assessing the risk of a complicated infection. We included 205 patients, of whom 41 patients were monitored with the COVID Box (mean age 70 and 53.7% male) and 164 in the control group (mean age 71.5 and 53% male). No difference was found in ED referrals between the intervention and control groups in our primary analysis. In the subgroup analysis, we found a nonsignificant trend that remote monitoring could reduce the ED referrals. While the overall study found comparable ED referrals between groups, the subgroup analysis suggested a promising prospect in reducing ED referrals due to remote monitoring of higher-risk patients with acute respiratory disease in primary care.
- 21 September 2024
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 42 (2)
Open AccessThe effect and implementation of the COVID Box, a remote patient monitoring system for patients with a COVID-19 infection in primary care: a matched cohort study
At the onset of the COVID-19 pandemic, the pressure on hospitals increased tremendously. To alleviate this pressure, a remote patient monitoring system called the COVID Box was developed and implemented in primary care. The aim was to assess whether the COVID Box in primary care could reduce emergency department (ED) referrals due to a COVID-19 infection. A matched cohort study was performed between December 2020 and June 2021. Patients with a COVID-19 infection in need of intensive monitoring based on the clinical judgement of their own general practitioner received the COVID Box in primary care combining home monitoring of vital parameters with daily video consultations. The control group was retrospectively matched by propensity score matching. We conducted a subgroup analysis in higher-risk patients with oxygen saturation measurements, considering oxygen saturation as a critical parameter for assessing the risk of a complicated infection. We included 205 patients, of whom 41 patients were monitored with the COVID Box (mean age 70 and 53.7% male) and 164 in the control group (mean age 71.5 and 53% male). No difference was found in ED referrals between the intervention and control groups in our primary analysis. In the subgroup analysis, we found a nonsignificant trend that remote monitoring could reduce the ED referrals. While the overall study found comparable ED referrals between groups, the subgroup analysis suggested a promising prospect in reducing ED referrals due to remote monitoring of higher-risk patients with acute respiratory disease in primary care.
- Open Access
- 11 March 2022
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 30 (9) , 431-435
Emergency Heart failure Mortality Risk Grade may help to reduce heart failure admissions
Introduction: Hospital admissions for heart failure (HF) are frequent and pose a heavy burden on health care resources. Currently, the decision to hospitalise is based on clinical judgement rather than on prognostic risk stratification. The Emergency Heart failure Mortality Risk Grade (EHMRG) was recently developed to identify high-risk HF patients in the emergency department (ED). Objective: To assess the ability of the EHMRG to predict 30-day mortality in Dutch HF patients visiting the ED and to evaluate whether the EHMRG could help to reduce the number of hospital admissions for decompensated HF. Methods: Patients visiting the ED for decompensated HF were included. The decision to hospitalise or discharge was based on clinical judgement. The EHMRG was calculated retrospectively. Based on their EHMRG, patients were stratified as very low risk, low risk, intermediate risk, high risk and very high risk. Results: In 227 patients (age 73 ± 12 years, 69% male) 30-day mortality was 11%. Mortality differed significantly among the EHMRG risk groups at 7‑day (p = 0.012) and 30-day follow-up (p < 0.01). Based on clinical judgement, 76% of patients were hospitalised. If decision-making had been based on EHMRG, the hospitalisation rate could have been reduced to 66% (p < 0.01), particularly by reducing hospitalisations in patients at low risk of death. Mortality in discharged patients, whether the decision was based on EHMRG or clinical judgement, was 0%. Conclusion: The EHMRG accurately differentiates between high- and low-risk decompensated HF patients visiting the ED, making it a promising tool to safely reduce the number of HF admissions.
- 11 March 2022
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 30 (9) , 431-435
Open AccessEmergency Heart failure Mortality Risk Grade may help to reduce heart failure admissions
Introduction: Hospital admissions for heart failure (HF) are frequent and pose a heavy burden on health care resources. Currently, the decision to hospitalise is based on clinical judgement rather than on prognostic risk stratification. The Emergency Heart failure Mortality Risk Grade (EHMRG) was recently developed to identify high-risk HF patients in the emergency department (ED). Objective: To assess the ability of the EHMRG to predict 30-day mortality in Dutch HF patients visiting the ED and to evaluate whether the EHMRG could help to reduce the number of hospital admissions for decompensated HF. Methods: Patients visiting the ED for decompensated HF were included. The decision to hospitalise or discharge was based on clinical judgement. The EHMRG was calculated retrospectively. Based on their EHMRG, patients were stratified as very low risk, low risk, intermediate risk, high risk and very high risk. Results: In 227 patients (age 73 ± 12 years, 69% male) 30-day mortality was 11%. Mortality differed significantly among the EHMRG risk groups at 7‑day (p = 0.012) and 30-day follow-up (p < 0.01). Based on clinical judgement, 76% of patients were hospitalised. If decision-making had been based on EHMRG, the hospitalisation rate could have been reduced to 66% (p < 0.01), particularly by reducing hospitalisations in patients at low risk of death. Mortality in discharged patients, whether the decision was based on EHMRG or clinical judgement, was 0%. Conclusion: The EHMRG accurately differentiates between high- and low-risk decompensated HF patients visiting the ED, making it a promising tool to safely reduce the number of HF admissions.
- 16 July 2021
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 38 (6) , 845-847
COVID-19’s impact on the future of digital health technology in primary care
- 16 July 2021
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 38 (6) , 845-847
COVID-19’s impact on the future of digital health technology in primary care
- 30 November 2020
- Published by Springer Nature in Huisarts en wetenschap
- Vol. 63 (12) , 100
Nieuws onderzoek naar The Box ‘Stevit’
- 30 November 2020
- Published by Springer Nature in Huisarts en wetenschap
- Vol. 63 (12) , 100
Nieuws onderzoek naar The Box ‘Stevit’